Accelerating Low-Cost Production of Consistent, Safe & Scalable Vectors for Cell & Gene Therapy to Ensure Regulatory Compliance & Clinical Success
With growing cost pressures, increasing regulatory scrutiny, and safety concerns reshaping the viral vector landscape, the field is at a pivotal inflection point. Developers are seizing new opportunities to improve scalability, reduce COGs, and strengthening batch consistency through smarter, data-driven manufacturing.
Returning to Boston for its 4th year, the Viral Vector Process Development & Manufacturing Summit is the only industry-led meeting dedicated to advancing process development and CMC for AAV, LV, RV, and emerging vector delivery systems.
Join over 80+ experts from Sanofi, Ultragenyx, Cabaletta Bio, Kite Pharmaceuticals, UCB, Obsidian Therapeutics as they uncover practical solutions in process optimization, automation, and regulatory alignment that are transforming vector manufacturing in 2026.
The organization of the conference was really well done. The interactive sessions - both during the workshops and during the main conference - were a key component that I really enjoyed.
Jorge Santiago-Oritz, Vice President - Chemistry, Manufacturing, Controls & Regulatory Affairs, Apertura Gene Therapy, 2025 Speaker
I’m excited to speak at the 2026 Viral Vector Process Development and Manufacturing Summit -it’s an excellent opportunity to spotlight challenges and innovations shaping the future of gene therapy manufacturing. Engaging with experts across industry and regulation to exchange perspectives is essential for advancing both quality and access in this rapidly evolving field.
Brett Howard, Senior Director, US Regulatory Policy, US Pharmacopeia, 2026 Speaker
Explore The Full Event Guide
- 16+ expert speakers from the likes of Sanofi, Ultragenyx, NCI, USP, Apertura, and Rocket Pharma
- 2 days of cutting-edge content tackling the toughest challenges in reducing COGs, improving process consistency, and scaling up viral vector production
- 5 Interactive sessions and 2 hours of dedicated networking
- Dedicated sessions on upstream and downstream streamlining
- Global perspectives on regulatory harmonization and pharmacopeial alignment
Official Partners
Expertise Partners
Innovation Partners
Exhibition Partner
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.